Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    In vivo label-free optical signatures of chemotherapy response in human pancreatic ductal adenocarcinoma patient-derived xenografts

    Pancreatic cancer is a devastating disease often detected at later stages, necessitating swift and effective chemotherapy treatment. However, chemoresistance is common and its mechanisms are poorly understood....

    Jaena Park, Janet E. Sorrells, Eric J. Chaney in Communications Biology (2023)

  2. No Access

    Article

    Endoscopic ultrasound-guided versus percutaneous drainage for the management of post-operative fluid collections after distal pancreatectomy

    Post-operative pancreatic fluid collections (POPFCs) can be drained using percutaneous or endoscopic approaches. The primary aim of this study was to compare rates of clinical success between endoscopic ultras...

    Delvise T. Fogwe, Jad P. AbiMansour, Mark J. Truty, Michael J. Levy in Surgical Endoscopy (2023)

  3. No Access

    Article

    A Novel ypTLM Staging System Based on LODDS for Gastric Cancer After Neoadjuvant Therapy: Multicenter and Large-Sample Retrospective Study

    The accuracy of the eighth AJCC ypTNM staging system on the prognosis of gastric cancer (GC) patients after neoadjuvant therapy (NAT) is controversial. This study aimed to develop and validate a novel staging ...

    Si-** Que, Qing Zhong, Qi-Yue Chen, Mark J. Truty, Su Yan in World Journal of Surgery (2023)

  4. Article

    Open Access

    Emergent pancreatectomy for neoplastic disease: outcomes analysis of 534 ACS-NSQIP patients

    While emergent pancreatic resection for trauma has been previously described, no large contemporary investigations into the frequency, indications, and outcomes of emergent pancreatectomy (EP) secondary to com...

    Michael R. Driedger, Carlos A. Puig, Cornelius A. Thiels, John R. Bergquist in BMC Surgery (2020)

  5. No Access

    Article

    Prospective longitudinal cohort study of patient recovery after major gastrointestinal surgery: is there a difference between minimally invasive and open approaches?

    Surgeons use the absence of post-operative complications to define recovery while patients define recovery as return to normal function. We aimed to better define the recovery process after minimally invasive ...

    Cornelius A. Thiels, Kristine T. Hanson, Kellie L. Mathis in Surgical Endoscopy (2020)

  6. No Access

    Article

    Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer

    NUC1031 is a first-in-class ProTide, that is a gemcitabine pro-drug designed to overcome putative mechanisms of resistance, including decreased expression of hENT/hCNT transporters, absence of activating enzym...

    Mansi Arora, James M. Bogenberger, Amro Abdelrahman in Cancer Chemotherapy and Pharmacology (2020)

  7. Article

    Open Access

    Radiolocalization of atypical lesions for intraoperative identification: technical factors, localization quality, success rates, patient safety, and spectrum of applications

    To retrospectively analyze perilesional technetium Tc-99m MAA injection for intraoperative localization of atypical soft-tissue and bone lesions within a single tertiary referral center in order to determine t...

    Jason R. Young, Andi E. Wallig, Nichole L. Fischer in World Journal of Surgical Oncology (2019)

  8. Article

    Open Access

    Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts

    High engraftment rates are critical to any patient-derived xenograft (PDX) program and the loss of PDX models due to the development of lymphoproliferative tumors (LTs) is costly and inefficient. We hypothesiz...

    Jennifer L. Leiting, Matthew C. Hernandez, Lin Yang in Scientific Reports (2019)

  9. No Access

    Article

    Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens

    Patient-derived xenografts (PDX) are clinically relevant human cancer models that can be used to guide individualized medicine. We aimed to generate PDX models from clinically obtained biopsy specimens (surgic...

    Matthew C. Hernandez, John R. Bergquist in Journal of Gastrointestinal Surgery (2019)

  10. No Access

    Article

    Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma

    The aim of this study was to investigate the impact of decreased skeletal muscle (SM) volume on survival outcomes in patients undergoing surgical resection for pancreatic ductal adenocarcinoma (PDAC).

    Motokazu Sugimoto, Michael B. Farnell in Journal of Gastrointestinal Surgery (2018)

  11. No Access

    Article

    Outcomes of Pancreaticoduodenectomy for Pancreatic Neuroendocrine Tumors: Are Combined Procedures Justified?

    Efficacy and outcomes of resection for pancreatic neuroendocrine tumors (pNET) are well established; specific data on outcomes for pancreaticoduodenectomy (PD), either alone or with combined procedures, are li...

    Cornelius A. Thiels, John R. Bergquist in Journal of Gastrointestinal Surgery (2016)

  12. No Access

    Article

    Metabolic Syndrome is Associated with Increased Postoperative Morbidity and Hospital Resource Utilization in Patients Undergoing Elective Pancreatectomy

    In patients undergoing elective partial pancreatectomy, our aim was to evaluate the effect of metabolic syndrome (MS) on postoperative mortality, morbidity, and utilization of hospital resources. Our hypothesis w...

    May C. Tee, Daniel S. Ubl, Elizabeth B. Habermann in Journal of Gastrointestinal Surgery (2016)

  13. No Access

    Article

    Pancreatoduodenectomy for Chronic Pancreatitis—Results of a Pain Relief and Quality of Life Survey 15 Years Following Operation

    Over the last 30 years, numerous developments in the management of chronic pancreatitis have occurred, leading to multiple surgical and non-surgical options.

    Kristopher P. Croome, May Tee, David M. Nagorney in Journal of Gastrointestinal Surgery (2015)

  14. No Access

    Article

    PROMIS for Laparoscopy

    We tested the responsiveness of the National Institutes of Health-sponsored Patient-Reported Outcomes Measures Information System (PROMIS) global health short form and a linear analog self-assessment for lapar...

    Juliane Bingener, Jeff A. Sloan, Drew K. Seisler in Journal of Gastrointestinal Surgery (2015)

  15. No Access

    Article

    Pancreaticoduodenectomy with Major Vascular Resection: a Comparison of Laparoscopic Versus Open Approaches

    Major vascular resection when necessary for margin control during pancreaticoduodenectomy is relatively universal with perioperative and oncological outcomes that are similar to those of patients undergoing a ...

    Kris P. Croome, Michael B. Farnell, Florencia G. Que in Journal of Gastrointestinal Surgery (2015)

  16. No Access

    Article

    Defining Perioperative Risk after Hepatectomy Based on Diagnosis and Extent of Resection

    Outcomes after hepatectomy have been assessed incompletely and have not been stratified by both extent of resection and diagnosis. We hypothesized that operative risk is better assessed by stratifying diagnose...

    Christopher R. Shubert, Elizabeth B. Habermann in Journal of Gastrointestinal Surgery (2014)

  17. No Access

    Article

    Modern Chemotherapy Mitigates Adverse Prognostic Effect of Regional Nodal Metastases in Stage IV Colorectal Cancer

    In colorectal cancer, the involvement of regional lymph nodes with metastasis is an established prognostic factor. The impact of the number of positive nodes on patient outcome with stage IV disease is not wel...

    Alan A. Thomay, David M. Nagorney, Steven J. Cohen in Journal of Gastrointestinal Surgery (2014)

  18. No Access

    Article

    Improved Long-Term Survival after Major Resection for Hepatocellular Carcinoma: A Multicenter Analysis Based on a New Definition of Major Hepatectomy

    Advances in the surgical management of hepatocellular carcinoma (HCC) have expanded the indications for curative hepatectomy, including more extensive liver resections. The purpose of this study was to examine...

    Andreas Andreou, Jean-Nicolas Vauthey in Journal of Gastrointestinal Surgery (2013)

  19. No Access

    Article

    Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection

    Resection of certain recurrent malignancies can prolong survival, but resection of recurrent pancreatic ductal adenocarcinoma is typically contraindicated because of poor outcomes.

    Ryan M. Thomas, Mark J. Truty in Journal of Gastrointestinal Surgery (2012)

  20. No Access

    Article

    Remnant Torsion Causing Budd-Chiari Syndrome After Right Hepatectomy

    Torsion or rotation of the remnant left liver after right hepatectomy is a potential cause of venous outflow obstruction. This can occur by external compression on the inferior vena cava or kinking of the left...

    Jeffrey K. Wang, Mark J. Truty, John H. Donohue in Journal of Gastrointestinal Surgery (2010)

previous disabled Page of 2